Results 131 to 136 of about 149 (136)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2007
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell +2 more
openaire +2 more sources
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell +2 more
openaire +2 more sources
Current Opinion in Oncology, 2003
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
The Epidemiology of Renal Cell Carcinoma
European Urology, 2011Kidney cancer is among the 10 most frequently occurring cancers in Western communities. Globally, about 270 000 cases of kidney cancer are diagnosed yearly and 116 000 people die from the disease. Approximately 90% of all kidney cancers are renal cell carcinomas (RCC).The causes of RCC are not completely known. We have reviewed known aetiologic factors.
Ljungberg, B +7 more
openaire +4 more sources
The Lancet
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young +7 more
openaire +2 more sources
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young +7 more
openaire +2 more sources
Radiotherapy for renal-cell carcinoma
The Lancet Oncology, 2014Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If given in a few (even single) fractions, but at a high fraction dose, stereotactic body radiotherapy becomes increasingly important in the management of renal-cell carcinoma, both in primary settings and in treatment of oligometastatic disease.
De Meerleer, Gert +11 more
openaire +3 more sources
New England Journal of Medicine, 1996